6-(Pyridin-3-yl)nicotinonitrile

Catalog No.: 
ACPWXO029
CAS No.: 
35989-11-8
Molecular Formula: 
C11H7N3
Molecular Weight: 
181.20
6-(Pyridin-3-yl)nicotinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$139.00InquiryInquiry
1g95%$409.00InquiryInquiry
5g95%$1189.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(Pyridin-3-yl)nicotinonitrile
IUPAC Name[2,3'-bipyridine]-5-carbonitrile
MDL No.MFCD15475303
Molecular FormulaC11H7N3
Molecular Weight181.20
SMILESN#CC1=CN=C(C2=CC=CN=C2)C=C1
InChI KeyFNWSCQGLFYBYGY-UHFFFAOYSA-N
CAS No.35989-11-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPWXO029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWUTP136 route compound structure diagram
    ACWUTP13633252-28-7In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACPWXO029 route product structure diagram
    ACPWXO02935989-11-8
Inquiry

2. ACPWXO029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOSPA207 route compound structure diagram
    ACOSPA207139585-70-9In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACPWXO029 route product structure diagram
    ACPWXO02935989-11-8
Inquiry

3. ACPWXO029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGADK973 route compound structure diagram
    ACGADK973329214-79-1In Stock
  2. Plus
  3. ACWUTP136 route compound structure diagram
    ACWUTP13633252-28-7In Stock
  4. Then
  5. ACPWXO029 route product structure diagram
    ACPWXO02935989-11-8
Inquiry

Comments (0)